Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ruth Vandenbroucke"'
Autor:
Ruth Vandenbroucke, Jean-Claude Mwanza, Douglas R. Anderson, Eleonore Savatovsky, William J. Feuer, Donald L. Budenz, Joyce C. Schiffman
Publikováno v:
Ophthalmology. 122:79-86
Purpose To explore the association between peripapillary atrophy (PPA) area and conversion from ocular hypertension (OHT) to glaucoma. Design Prospective, longitudinal cohort study of cases and controls. Participants We included 279 age-matched and f
Autor:
Giovanni Gregori, Gloria A. Nadayil, Potyra R. Rosa, Sophia Cuprill-Nilson, Byron L. Lam, John Guy, William J. Feuer, Mindy X. Wang, Xiaojun Zhang, Samuel P. Burke, Ruth Vandenbroucke
Publikováno v:
Ophthalmic surgery, lasersimaging retina. 47(9)
BACKGROUND AND OBJECTIVE: To determine macular retinal sublayer thickness changes in G11778A Leber hereditary optic neuropathy (LHON). PATIENTS AND METHODS: The authors performed a cross-sectional study by segmenting spectral-domain Cirrus OCT (Carl
Autor:
Joyce C. Schiffman, William J. Feuer, Michael A. Kass, Ruth Vandenbroucke, Donald L. Budenz, Mae O. Gordon, Douglas R. Anderson, Richard K. Parrish, Maria Cristina Wells-Albornoz
Publikováno v:
American journal of ophthalmology. 140(4)
Purpose To assess the reproducibility of determining whether an eye has developed optic disk deterioration by the Optic Disc Reading Center (ODRC) in the Ocular Hypertension Treatment Study (OHTS). Design Test-retest reproducibility study. Methods Ma
Autor:
Potyra R. Rosa, William J. Feuer, Ruth Vandenbroucke, Vittorio Porciatti, John Guy, Joyce C. Schiffman, Giovanni Gregori, Byron L. Lam
Publikováno v:
JAMA Ophthalmology. 132:428
Importance Establishing the natural history of G11778A Leber hereditary optic neuropathy (LHON) is important to determine the optimal end points to assess the safety and efficacy of a planned gene therapy trial. Objective To use the results of the pr
Autor:
Joyce C. Schiffman, Byron L. Lam, Ruth Vandenbroucke, William J. Feuer, John Guy, Potyra R. Rosa, Vittorio Porciatti, Fawzi Abukhalil
Publikováno v:
Investigative Opthalmology & Visual Science. 55:841
Purpose To report the serial evaluation of asymptomatic eyes of subjects with mutated G11778A mitochondrial DNA. Methods Forty-five asymptomatic G11778A Leber hereditary optic neuropathy (LHON) carriers and two patients with the mutation who develope
Autor:
Mary B. Hall, John M. Ramocki, Jody R. Piltz-Seymour, Donald F. Everett, Lea Morton, Robert A. Copeland, Stacey S. Goldstein, Michele C. Lim, Harry A. Quigley, Silvia Orengo-Nania, Bernard Becker, Heather Johnson, Richard K. Parrish, Manju Sharma, Teresa A. Long, Karen Clark, David S. Friedman, Cheryl L. Vitelli, Ditte J. Hess, Annisa L. Jamil, Michael A. Kass, Fermin P. Ballesteros, Lisa Levin, Fortunata Darmody, Carol J. Pollack-Rundle, Hina N. Ahmed, Celso Tello, Shan C. Lin, Maria Cristina Wells-Albornoz, Robb R. Shrader, Laura L. Schulz, Betsy Hornbeck, Ellen Long, Donald J. Zack, Jo Anne Katz, Nina C. Mondoc, Kathleen A. Lamping, Robert J. Derick, Julia A. Beiser, Felicia Keel, Kathryn R. Sherman, Allan J. Flach, John Connett, Alan L. Robin, Ronald L. Gross, Jeffrey M. Liebmann, Joern B. Soltau, Sandy Lear, Terry J. Bergstrom, Ramzi Hemady, Denise M. Owensby, William M. Bourne, Janice T. Petner, Arthur L. Schwartz, Shannan E. Bandermann, Ruth Vandenbroucke, Michelle A. Tehranisa, James D. Brandt, Linda M. Zangwill, Douglas R. Anderson, Valerie Margol, Charles J. Patorgis, Robert Ritch, Ingrid J. Clark, Allan E. Kolker, Osaro A. Okuonghae, John M. O'Grady, Joyce C. Schiffman, Y. P. Dang, Deborah Lee, Melanie Gutkowski, Robin L. Montgomery, Sayoko E. Moroi, Mark B. Sherwood, Rachel Scott, Simon K. Law, Deborah Darnley-Fisch, Mark S Juzych, Eydie Miller, Donald L. Budenz, Camilele M. Hylton, Keri Dirkes, N. Douglas Baker, Steven J. Gedde, Donald A. Abrams, Kimberly E. Cello, Deborah A. Dunn, Pamela M. Frady, Steven L. Mansberger, George A. Cioffi, Paul McManus, Deborah L. Simon, Bettina J. Modica, John L. Keltner, Emily L. Patterson, Myron Yanoff, Marianne L. Perry, Juanjuan Fan, Nancy J. Tvedt, Jean L. Walker, Shelly R. Smith, Kathyrne McKinney, Aldo Fantin, Dale K. Heur, Benita D. Slight, Karen D. Schacht, Francisco Fantes, Mark L. McDermott, Pamela A. Sample, Anjali M. Bhorade, Thomas S. Harbin, Carla J. Siegfried, Salvador Murillo, J. Philip Miller, Shaban Demirel, Marilyn A. Sponzo, Patricia A. Morris, Linda A. Van Conett, Eve J. Higginbotham, Barry R Davis, Michael V. Drake, Sheila M. Rock, Nauman R. Imami, Donna Leef, Madeline L. Del Calvo, Howard S. Weiss, J. Rigby Slight, Cheryl McGill, William J. Feuer, Anne L. Coleman, Dale K. Heuer, Juan Allen, David M. Lehmann, Edward M. Barnett, Clete Clark, Claude L Cowan, Jo Anne M Fraser, Irvin P. Pollack, Chris A. Johnson, Paul Weber, Mary Jameson, Jo Ann A Giaconi, Ivan R. Schwab, Sandra Quirin, David C. Herman, Montana L. Hooper, Judit Mohay, Steven M. Kymes, Bhupinder S. Dhillon, Julie M. Wright, Elizabeth Carnegie, Becky A. Nielsen, Ronald Munson, Monica Y. Allen, Teresa A. Roediger, M. Roy Wilson, G. Richard Bennett, Robert N. Weinreb, John A. Keltner, Allen D. Beck, Mary Bednarski, Henry D. Jampel, Christina A. Bruno, Bobbie Ballenberg, Kevin L. Powdrill, Anastasias Costarides, Anne M. Boeckl, Prithvi S. Sankar, Richard S. Baker, Robyn Priest-Reed, Douglas E. Gaasterland, Gregory L. Skuta, Lindsay C. Bennett, Jeffrey J. Casper, Frank S. Ashburn, Diane Moore, Nathan Congdon, Bret A Hughes, Mae E. Gordon, Robert L. Stamper, Douglas H. Johnson, Richard A. Levine
Publikováno v:
Investigative Opthalmology & Visual Science. 47:3896
To evaluate whether baseline visual field data and asymmetries between eyes predict the onset of primary open-angle glaucoma (POAG) in Ocular Hypertension Treatment Study (OHTS) participants.A new index, mean prognosis (MP), was designed for optimal
Autor:
Robert Nussenblatt, Tobias Samo, Joyce A. Korvick, Michele Donithan, Michael C. Smith, Joan M. Kline, Dale Henderly, Karen L. Binder, Gary Stewart, Mary Ann Simanello, Matthew D. Davis, William Freeman, Alan H. Friedman, B. Barron, Camara P. Jones, Suzette Chafey, Richard Haubrich, Pamela Clogston, Karen Tolson, Kathleen Naughton, Jan A. Markowitz, Milana R. Isaacson, Sarah H. Cheeseman, Paul Mendez, Jose I. Quiceno, Harry Kachadoorian, Henry S. Sacks, Yuan-I Min, Larry Hubbard, Dorothy N. Friedberg, Byron W. Brown, Jude Brown-Bellamy, James P. Dunn, Harmon Smith, James Larson, John P. Phair, James Tonascia, John P. Mills, Stephen A. Spector, Susanne Wise-Campbell, Amy C. Klemm, T. Flynn, Maria Agres-Segal, Elaine Chuang, Gordon R. Sandford, Lee M. Jampol, Ronald Gross, Nancy Fink, Bruce Polsky, Robert L. Murphy, Douglas A. Jabs, Pamela S. Clogston, Leland Rickman, Alexander Irvine, Adrienne Addessi, Rudolph Franklin, Colette Severin, Stuart Seiff, Rosetta M. Owens, Ginger Freitag, Dolores Hurlburt, Linda Kastorff, Rosemary King, Kathleen Miner, Mark A. Jacobson, Lois Eldred, Gholam Peyman, Brian Conway, Gary N. Holland, Suzanne Thomas, John W. Gittinger, Judith Feinberg, W. David Hardy, Mark L. Van Natta, Janet T. Holbrook, Marilyn Vanderhoof-Young, Murk-Hein Heinemann, Kathleen Squires, Lesley J. MacArthur, Jo Leslie, Richard A. Lewis, Lisa Welch, Ruth Vandenbroucke, Richard Mowery, Ronald Brookmeyer, Charlotte Gerczak, David S. Weinberg, Stephen Singer, Janet Davis, Chris Kimbrell, John Dodge, William R. Freeman, Maria Stevens, Victor Fainstein, Susan S. Ellenberg, James O'Donnell, Kevin Frost, Colette Tuttle, Deborah Greenspan, Steven Teich, Colin Jordan, Douglas Dieterich, Yvonne Magli, Norma Justin, T. Clark, Alfred J. Saah, John G. Bartlett, Curtis L. Meinert, Fred R. Sattler, Tony W. Cheung, J. L. Meinert, Vivian E. Brown, Holly Fall, Rene Webb, James Grizzle, Maxine Wanner, Timothy J. Peterson, Robert A. Hughes, Linda Meixnert, Deborah J. Nowakowski, Alice L. Sternberg, Linda Apuzzo, Jacqueline Hoffman, Jane Armstrong, Millie Espinal, Charlene R. Levine, Betty J. Collison, Cynthia Le-Count, Laura Coleson
Publikováno v:
Archives of Internal Medicine. 155:65
Background: The Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial compared the use of either ganciclovir or foscarnet for the initial treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. We previously re